Suppr超能文献

卡托普利用于慢性肾衰竭和肾移植患者的顽固性高血压

Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.

作者信息

Hamilton D V, Evans D B, Maidment G, Pryor J S

出版信息

J R Soc Med. 1981 May;74(5):357-62.

Abstract

The converting-enzyme inhibitor, captopril, was given to ten patients with refractory severe hypertension of renal origin: 6 patients had chronic renal failure, 3 patients had hypertension following renal transplantation, and one patient had hypertension and congestive cardiac failure. Control of blood pressure was achieved with doses from 78 to 400 mg/day. Severe hyperkalaemia occurred in one patients, ageusia (dose dependent) in another, and one patients withdrew from treatment because of nausea.

摘要

给10例顽固性肾源性重度高血压患者服用转换酶抑制剂卡托普利:6例患有慢性肾衰竭,3例在肾移植后出现高血压,1例患有高血压和充血性心力衰竭。通过每日78至400毫克的剂量实现了血压控制。1例患者出现严重高钾血症,另1例出现味觉丧失(剂量依赖性),1例患者因恶心退出治疗。

相似文献

7
Captopril in hypertension after renal transplantation.卡托普利用于肾移植术后高血压
Postgrad Med J. 1984 Feb;60(700):132-4. doi: 10.1136/pgmj.60.700.132.

本文引用的文献

9
Bilateral nephrectomy prior to renal transplantation.肾移植前双侧肾切除术。
Br J Surg. 1976 Jul;63(7):512-6. doi: 10.1002/bjs.1800630704.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验